TW200630345A - Methods for preparing indazole compounds - Google Patents

Methods for preparing indazole compounds

Info

Publication number
TW200630345A
TW200630345A TW094138277A TW94138277A TW200630345A TW 200630345 A TW200630345 A TW 200630345A TW 094138277 A TW094138277 A TW 094138277A TW 94138277 A TW94138277 A TW 94138277A TW 200630345 A TW200630345 A TW 200630345A
Authority
TW
Taiwan
Prior art keywords
methods
indazole compounds
compounds
formula
protein kinases
Prior art date
Application number
TW094138277A
Other languages
English (en)
Chinese (zh)
Inventor
Srinivasan Babu
Raymond Dagnino Jr
Aubrey Haddach
Mark Bryan Mitchell
Michael Allen Ouellette
James Edward Saenz
Jayaram Kasturi Srirangam
Shu Yu
Scott Edward Zook
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of TW200630345A publication Critical patent/TW200630345A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
TW094138277A 2004-11-02 2005-11-01 Methods for preparing indazole compounds TW200630345A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62471904P 2004-11-02 2004-11-02
US62480104P 2004-12-14 2004-12-14

Publications (1)

Publication Number Publication Date
TW200630345A true TW200630345A (en) 2006-09-01

Family

ID=35456957

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094138277A TW200630345A (en) 2004-11-02 2005-11-01 Methods for preparing indazole compounds

Country Status (9)

Country Link
EP (1) EP1814859A2 (fr)
KR (1) KR20070085727A (fr)
AU (1) AU2005300241A1 (fr)
CA (1) CA2591313A1 (fr)
IL (1) IL183605A0 (fr)
MX (1) MX2007006554A (fr)
RU (1) RU2007120635A (fr)
TW (1) TW200630345A (fr)
WO (1) WO2006048761A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2136284A1 (en) * 1971-02-08 1972-08-31 Diamond Shamrock Corp., Cleveland, Ohio (V.StA.) Herbicidal pyrrolidinyl-carboxanilides - from arylisocyanates and pyrrolidines in organic solvents
PE20010306A1 (es) * 1999-07-02 2001-03-29 Agouron Pharma Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa

Also Published As

Publication number Publication date
KR20070085727A (ko) 2007-08-27
WO2006048761A3 (fr) 2006-06-22
AU2005300241A2 (en) 2006-05-11
WO2006048761A2 (fr) 2006-05-11
AU2005300241A1 (en) 2006-05-11
MX2007006554A (es) 2007-06-19
IL183605A0 (en) 2007-09-20
EP1814859A2 (fr) 2007-08-08
RU2007120635A (ru) 2008-12-10
CA2591313A1 (fr) 2006-05-11

Similar Documents

Publication Publication Date Title
TW200614990A (en) Methods for preparing indazole compounds
IL260127B (en) mek inhibitors and methods of using them
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
IN2014KN02886A (fr)
ATE532789T1 (de) Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren
ATE493418T1 (de) Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren
TW200607505A (en) Fused heterocyclic kinase inhibitors
UA95244C2 (ru) Соединения и способ модулирования активности киназ, и показания для их применения
UA94097C2 (ru) Пиридил- и пиримидинилзамещенные производной пиррола, тиофена и фурана как ингибиторы киназ
TW200801008A (en) Protein kinase inhibitors
TW200621721A (en) Methods of preparing indazole compounds
ATE432281T1 (de) Pyrrolotriazin-kinasehemmer
MY151455A (en) Carbonylamino pyrrolopyrazoles, potent kinase inhibitors
TN2009000142A1 (en) Bicyclic triazoles as protein kinase modulators
HK1136292A1 (en) Substituted pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
MX2008001538A (es) Aril piridinas y metodos para su uso.
ATE419249T1 (de) Inhibitoren von mitotischem kinesin
NO20070589L (no) Mitotiske kinesin-inhibitorer.
HK1074840A1 (en) Novel dithiolopyrrolones with therapeutic activity
UA96427C2 (en) Substituted pyrazole compounds
TW200630345A (en) Methods for preparing indazole compounds
TW200801020A (en) Improved methods for preparing benzofused heteroaryl amide derivatives of thienopyridines
UA92047C2 (uk) Карбоніламінопіролпіразоли - потужні інгібітори кінази
WO2007026221A3 (fr) Procede ameliores d'elaboration de derives d'heteroaryl amide benzocondenses de thienopyridines
UA88794C2 (en) Pyrrolopyrazoles, potent kinase inhibitors